The biological activity method is the only in vitro analysis method that reflects the clinical effect of liposome drugs. In terms of in vitro bioactivity evaluation of liposomes, CD Formulation has the most advanced in vitro evaluation instruments and concepts, equipped with a variety of dissolution & release equipment, penetration equipment, transdermal equipment, and established a variety of in vitro evaluation models for different dosage forms such as oral liposome, topical liposomes, injection liposomes, etc. We are working with a number of pharmaceutical customers to continuously expand our capabilities in drug bioequivalence evaluation in vitro, provide customers with high-quality and efficient overall solutions and strategies, and continue to help the development and marketing of liposome drugs.
In vitro bioactivity evaluation is the determination of the active ingredients and efficacy of liposome drugs, which is a very important part of drug quality control. Biological activity detection runs through the entire life cycle of liposome drugs, from early target discovery, antibody screening, transition to CMC stage for production, clinical application, and finally marketing, which will involve the analysis of biological activity. Therefore, it is extremely important to select an efficient, rapid and accurate method for the determination of biological activity.
Liposomes are usually used as carriers to deliver drugs, but the actual active substance is the encapsulated active substance. Therefore, the in vitro activity of the main active substance should be paid attention to when evaluating the biological activity of liposomes. In addition, the mechanism of action of each bioactive substance is different, especially for targeted modified liposomes, we need to screen different in vitro activity evaluation strategies according to different targeted modifiers. Our services include but are not limits to the following.
Fig.1 Our workflow for liposome in vitro bioactivity evaluation. (CD Formulation)
Platforms | Specifics |
Cytological experimentPlatform | We provide cytological experimental models of different types of targets, and hundreds of disease models have been developed.
|
In vitro evaluation system |
|
Technology: shikotin liposomes technology
Journal: Phytomedicine
IF: 7.9
Published: 2022
Results: In this study, the authors developed shikotin liposomes, which showed good slow-release behavior and successfully improved the antibacterial efficiency of SH against Staphylococcus aureus. The mechanism of the designed SH-liposome's antibacterial activity against Staphylococcus aureus is related to the irreversible damage to the bacterial cell wall and membrane. In addition, SH-liposome preparations play a beneficial role in the treatment of MRSA-infected burn wounds. Overall, SH-liposome is a promising novel and effective.
For many years, CD has helped many customers study the in vitro bioactivity of liposomes, and our team of scientists and experts have the expertise and knowledge to answer your questions. If you are interested in our services, please contact us at your convenience.
References